STOCK TITAN

Quipt Home Medical Corp - QIPT STOCK NEWS

Welcome to our dedicated news page for Quipt Home Medical (Ticker: QIPT), a resource for investors and traders seeking the latest updates and insights on Quipt Home Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Quipt Home Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Quipt Home Medical's position in the market.

Rhea-AI Summary
Quipt Home Medical Corp. announces voting results from annual meeting, elects directors, appoints auditors, and approves 2024 Equity Incentive Plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
-
Rhea-AI Summary
Quipt Home Medical Corp. to participate in the 36th Annual Roth Conference, focusing on respiratory care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
none
-
Rhea-AI Summary
Quipt Home Medical Corp. (QIPT) reports strong financial results for Q1 2024 with revenue of $65.4 million, a 60% increase from Q1 2023, and 2% sequential organic growth. Adjusted EBITDA margin of 23.5% and net income of $(0.6) million. The Company maintains a conservative balance sheet with $18.3 million cash on hand and total credit availability of $41 million. Operational highlights include a 56% increase in customer base to 155,434 unique patients served and 47% increase in set-ups/deliveries. The Company's resupply program drives 83% recurring revenue base and 49% of recurring revenue mix. Management emphasizes strategic investments for organic growth and expansion into continuum markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.16%
Tags
Rhea-AI Summary
Quipt Home Medical Corp. will announce its fiscal first quarter 2024 financial results on February 14, 2024. The conference call for the investment community will be hosted by CEO Gregory Crawford and CFO Hardik Mehta on February 15, 2024. The company is a U.S. based home medical equipment provider, focused on end-to-end respiratory care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.74%
Tags
-
Rhea-AI Summary
Quipt Home Medical Corp. (QIPT) files preliminary short form base shelf prospectus to offer up to C$300,000,000 of securities, replacing its previous short form base shelf prospectus and registration statement. The Shelf Prospectus will enable the Company to access new capital or issue securities in connection with strategic acquisitions if and when needed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
-
Rhea-AI Summary
Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT) reports very strong adjusted EBITDA % of revenue of 23.5% for fiscal Q4 and 22.8% for fiscal year 2023, with a 59% increase in revenue compared to the previous year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
Rhea-AI Summary
Quipt Home Medical Corp. (QIPT) to Announce Q4 and Full Year 2023 Financial Results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
-
Rhea-AI Summary
Quipt Home Medical Corp. has acquired a business with operations in Mississippi, Texas, and Louisiana, reporting unaudited annual revenues of $9 million and anticipated Adjusted EBITDA of $2 million post integration. The acquisition adds scale with ten locations, 17,500 active patients, and 1,900 referring physicians. The acquisition is expected to assist with organic growth initiatives and increase resupply revenue. Quipt's current active patients are now 287,500, with 34,400 referring physicians and 125 locations across 26 U.S. states. The acquisition increases Quipt's annual revenues by $9 million and is expected to increase Adjusted EBITDA by $2 million. The acquisition purchase price is at historical multiples paid by the Company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.15%
Tags
-
Rhea-AI Summary
Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT) reported strong financial results for Q3 fiscal 2023 with a 64% increase in revenues year-over-year, a 4% sequential organic growth, and an adjusted EBITDA margin of 23%. The company's customer base and unique set-ups/deliveries also witnessed significant growth. Additionally, the company's investment in DMEScripts LLC aims to align itself with industry peers and drive future growth in e-prescription usage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
Rhea-AI Summary
Quipt Home Medical Corp. will host its Fiscal Q3 2023 earnings conference call and audio webcast on August 15, 2023 at 10:00 a.m. (ET).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
Quipt Home Medical Corp

Nasdaq:QIPT

QIPT Rankings

QIPT Stock Data

164.18M
40.49M
3.81%
45.08%
1.35%
Dental Laboratories
Manufacturing
Link
United States
Wilder

About QIPT

protech home medical is a rapidly growing leader in the provision of clinical respiratory equipment and service to patients.